PPHM News - SmartMoney.com http://www.smartmoney.com Investing, Saving and Personal Finance en-us Copyright 2013 Dow Jones & Company, Inc. All Rights Reserved. http://www.smartmoney.com/rss/images/sm_logo_65x31.gif SmartMoney.com http://www.smartmoney.com 65 31 Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer http://www.smartmoney.com/news/PR/?story=PR-20130520-000724&cid=951 Mon, 20 May 2013 08:47:00 -0400 Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer Phase III Registration Trial of Investigational Immunotherapy... (Source: Press Release) http://www.smartmoney.com/news/PR/?story=PR-20130520-000724&cid=951 PR Peregrine Pharmaceuticals' Immunotherapy Bavituximab to Be Highlighted in Three Clinical Data Presentations at 2013 ASCO Annual Meeting http://www.smartmoney.com/news/PR/?story=PR-20130516-001001&cid=951 Thu, 16 May 2013 08:30:00 -0400 Peregrine Pharmaceuticals' Immunotherapy Bavituximab to Be Highlighted in Three Clinical Data Presentations at 2013 ASCO Annual Meeting Presentations Include Data From Two Phase II Bavituximab Trials... (Source: Press Release) http://www.smartmoney.com/news/PR/?story=PR-20130516-001001&cid=951 PR Peregrine Announces Completion of Patient Enrollment in Breast Cancer Clinical Trial for Bavituximab http://www.smartmoney.com/news/PR/?story=PR-20130429-000888&cid=951 Mon, 29 Apr 2013 08:29:59 -0400 Peregrine Announces Completion of Patient Enrollment in Breast Cancer Clinical Trial for Bavituximab Data From the Trial to Be Presented at 2013 ASCO Annual Meeting... (Source: Press Release) http://www.smartmoney.com/news/PR/?story=PR-20130429-000888&cid=951 PR